Clear Cell Ovarian Carcinoma Following Long-Term Tamoxifen Use. (Q34248606)

31 July 2017

Clear Cell Ovarian Carcinoma Following Long-Term Tamoxifen Use. (English)

1 reference

31 July 2017

1 reference

1 reference

T. Scott Jennings

1

1 reference

PubMed ID

11348273

31 July 2017

Mary E. Haddad

series ordinal

2

1 reference

PubMed ID

11348273

31 July 2017

Timothy M. Smith

series ordinal

3

1 reference

31 July 2017

1 March 1999

1 reference

31 July 2017

1 reference

31 July 2017

5

1 reference

31 July 2017

2

1 reference

31 July 2017

132-135

1 reference

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00137.X

Gynaecologic effects of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00137.X

Ovarian cancer and long-term tamoxifen in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00137.X

Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00137.X

Primary fallopian tube adenocarcinoma in situ associated with adjuvant tamoxifen therapy for breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00137.X

10.1046/J.1524-4741.1999.00137.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11348273